Malaria and iron-deficient anemia during pregnancy pose considerable risks for the mother and newborn. Intermittent Preventive Treatment during pregnancy with sulphadoxine-pyrimethamine (IPTp-SP) and iron supplement to prevent anemia to all pregnant women receiving antenatal care (ANC) services is highly recommended. However, their compliance remains low. This study aimed at identifying factors influencing non-compliance of medications among pregnant women.
Communications Specialist with 7+ years in public health and development, focused on strategic storytelling and digital engagement.
Read more: https://www.linkedin.com/in/julieth-mongi-48742610b/